Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
BMS-986226 is a monoclonal antibody that targets ICOS (inducible T-cell costimulator, CD278) to activate T-cells in the immune anti-tumor response (NCI Drug Dictionary).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|BMS-986226 + Ipilimumab||BMS-986226 Ipilimumab||0||1|
|BMS-986226 + Nivolumab||BMS-986226 Nivolumab||0||1|